Hepion Pharmaceuticals News - HEPA

Company Name	Stock Ticker Symbol	Market	Type
Hepion Pharmaceuticals Inc	HEPA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.31	06:07:59

Open Price	Low Price	High Price	Close Price	Prev Close
				1.31

more quote information »

Recent News

Date	Time	Source	Heading
5/08/2024	9:05	IHNW	FeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
4/19/2024	16:30	GLOBE	Hepion Pharmaceuticals Initiates Wind-Down Activities in..
2/16/2024	09:02	EDGAR2	Form 8-K - Current report
2/16/2024	08:00	GLOBE	Hepion Pharmaceuticals Announces Exercise of Warrants for..
2/14/2024	15:38	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
1/03/2024	17:15	GLOBE	Hepion Pharmaceuticals to Present at NASH-TAG 2024
1/03/2024	16:30	EDGAR2	Form 8-K - Current report
12/07/2023	08:00	GLOBE	Hepion Pharmaceuticals Announces Restructuring Plan to..
11/28/2023	16:15	GLOBE	Hepion Pharmaceuticals to Present at the 7th Obesity & NASH..
11/13/2023	16:05	GLOBE	Hepion Pharmaceuticals Announces Major Reductions in Liver..
11/10/2023	08:50	GLOBE	Hepion Pharmaceuticals Schedules Conference Call to Review..
11/09/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
10/25/2023	08:30	GLOBE	Hepion Pharmaceuticals’ Rencofilstat Demonstrates..
9/29/2023	08:00	GLOBE	Hepion Pharmaceuticals Announces $5.0 Million Registered..
9/21/2023	16:05	GLOBE	Hepion Pharmaceuticals to Participate in 2023 Cantor Global..
9/21/2023	08:00	GLOBE	New Anti-Cancer Opportunities Revealed for Hepion..
9/19/2023	09:00	GLOBE	Hepion Pharmaceuticals Discovers Novel Rencofilstat Action..
9/18/2023	08:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/14/2023	08:45	GLOBE	Rencofilstat Produces Positive Outcomes in Translational..
9/06/2023	16:40	EDGAR2	Form 8-K - Current report
9/06/2023	16:30	GLOBE	Hepion Pharmaceuticals Announces Management Changes
7/24/2023	16:04	EDGAR2	Form 8-K - Current report
7/21/2023	16:41	EDGAR2	Form 8-K - Current report
7/21/2023	16:39	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
6/15/2023	16:45	GLOBE	Hepion Pharmaceuticals to Present Two Posters at EASL..
6/15/2023	08:22	GLOBE	Hepion Pharmaceuticals Announces Passing of Key Safety..
5/24/2023	16:45	GLOBE	Hepion Pharmaceuticals to Highlight AI-POWR™ at the 2023..
5/22/2023	07:00	GLOBE	Hepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial..
5/19/2023	16:05	GLOBE	Hepion Pharmaceuticals Schedules Conference Call to Review..
5/10/2023	11:15	GLOBE	Hepion Pharmaceuticals, Inc. Announces Reverse Stock Split